Table 4 Multivariate survival analysis of the association between prognostic variables and survival in cervical cancer patients
From: Clinical significance of OCT4 and SOX2 protein expression in cervical cancer
Variables | Disease-free survival | Overall survival | ||
|---|---|---|---|---|
HR [95Â % CI] | P value | HR [95Â % CI] | P value | |
FIGO stage (≥ IIB) | 8.67 [2.77–27.11] | <0.001 | 4.33 [1.06–17.72] | 0.041 |
Tumor size (>4 cm) | 1.16 [0.47–2.84] | 0.739 | 1.79 [0.54–5.92] | 0.340 |
LN metastasis | 1.72 [0.57–5.23] | 0.334 | 1.60 [0.40–6.41] | 0.500 |
OCT4+ | 3.75 [1.24–11.55] | 0.117 | 11.23 [1.31–95.64] | 0.027 |
SOX2 + | 0.47 [0.18–1.20] | 0.019 | 0.22 [0.06–0.72] | 0.013 |